Experimental autoimmune encephalomyelitis (EAE), an experimental model for the study of multiple sclerosis, is an autoimmune disease of the central nervous system that can be induced in a number of species by immunization with myelin basic protein (MBP). MBP-reactive CD4 + T cells, predominantly expressing the V38.2 T cell receptor (TCR), migrate from the peripheral lymphoid organs and initiate the inflammatory response in the brain. We have previously shown that a single intrathymic injection of MBP or its major encephalitogenic peptide (p71-90), but not a nonencephalitogenic peptide (p21-40), induces antigen-specific systemic tolerance and inhibits the induction of EAE in Lewis rats. In this study, we investigated the mechanisms of induction and maintenance of acquired thymic tolerance in this model. First, we investigated which thymic cell is responsible for "induction" of systemic tolerance. Thymic dendritic-enriched cells, isolated by plastic adherence, when incubated in vitro with p71-90 and injected intravenously into Lewis rats, were capable of preventing the development of EAE, but his protection was lost in thymectomized recipients. In addition, intravenous injection of thymic dendritic cells isolated from animals that had been previously injected intrathymically with p71-90 but not p21-40 also prevented the development of EAE. Second, to determine the "effector" mechanisms involved in acquired thymic tolerance, we compared TCR expression in the brains of animals with actively induced EAE with TCR expression in animals that received intrathymic injection of p71-90 or p21-40. Using a semiquantitative reverse transcription-polyrnerase chain reaction (RT-PCR) technique, we found increased expression of CD4 and Vfl8.2 message in brains of immunized animals compared with those of naive animals. In animals intrathymically injected with p71-90 but not p21-40, CD4 and VBS.2 transcript levels were significantly reduced compared with immunized controls. Immunohistologic studies of brain tissue and spleens with specific V~8.2 and control V310 monoclonal antibodies confirmed these observations in vivo. These findings, taken together with recent data demonstrating that activated T cells circulate through the thymus, suggest that interaction of thymic dendritic cells with specific TCR of activated peripheral T cells can lead to inactivation of these antigen-specific cells and confirm the role of VB8.2-expressing T cells in EAE.
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Experimental autoimmune encephalomyelitis (EAE), an experimental model for the study of multiple sclerosis, is an autoimmune disease of the central nervous system that can be induced in a number of species by immunization with myelin basic protein (MBP). MBP-reactive CD4 + T cells, predominantly expressing the V38.2 T cell receptor (TCR), migrate from the peripheral lymphoid organs and initiate the inflammatory response in the brain. We have previously shown that a single intrathymic injection of MBP or its major encephalitogenic peptide (p71-90), but not a nonencephalitogenic peptide (p21-40), induces antigen-specific systemic tolerance and inhibits the induction of EAE in Lewis rats. In this study, we investigated the mechanisms of induction and maintenance of acquired thymic tolerance in this model. First, we investigated which thymic cell is responsible for "induction" of systemic tolerance. Thymic dendritic-enriched cells, isolated by plastic adherence, when incubated in vitro with p71-90 and injected intravenously into Lewis rats, were capable of preventing the development of EAE, but his protection was lost in thymectomized recipients. In addition, intravenous injection of thymic dendritic cells isolated from animals that had been previously injected intrathymically with p71-90 but not p21-40 also prevented the development of EAE. Second, to determine the "effector" mechanisms involved in acquired thymic tolerance, we compared TCR expression in the brains of animals with actively induced EAE with TCR expression in animals that received intrathymic injection of p71-90 or p21-40. Using a semiquantitative reverse transcription-polyrnerase chain reaction (RT-PCR) technique, we found increased expression of CD4 and Vfl8.2 message in brains of immunized animals compared with those of naive animals. In animals intrathymically injected with p71-90 but not p21-40, CD4 and VBS.2 transcript levels were significantly reduced compared with immunized controls. Immunohistologic studies of brain tissue and spleens with specific V~8.2 and control V310 monoclonal antibodies confirmed these observations in vivo. These findings, taken together with recent data demonstrating that activated T cells circulate through the thymus, suggest that interaction of thymic dendritic cells with specific TCR of activated peripheral T cells can lead to inactivation of these antigen-specific cells and confirm the role of VB8.2-expressing T cells in EAE.
E
xperimental autoimmune encephalomyelitis (EAE) 1 is an inflammatory disease of the central nervous system that can be induced in a number of species by immunization with merit of self-tolerance and may also play a role in acquired tolerance in experimental autoimmune (6) (7) (8) (9) and transplantation (10-14) models. We have recently shown that injection of MBP or its encephalitogenic peptide p71-90 into the thymus induces systemic tolerance and prevents development of EAE in the Lewis rat model. Immunohistologically, there was marked reduction of mononudear cell infiltrates and absent activation and inflammatory cytokines in the brains of intrathymicaUy tolerized animals (15) . The cellular interactions in the thymus between specific T cells and thymic APCs that ultimately lead to induction of systemic tolerance and the effector mechanisms of acquired thymic tolerance are not well understood. Agus et al. reported that activated but not resting T cells circulate through the thymus and may stay there for a prolonged period of time (16) . Furthermore, dendritic cells are known for their ability to migrate to T cell-dependent areas of lymphoid organs (17) . These observations provide potential mechanisms whereby presentation of immunogenic peptides by specific thymic APCs to activated peripheral T cells circulating through the thymus might lead to specific T cell inactivation (18) and specific systemic tolerance. We now report results of studies directed at defining the thymic APCs that induce specific peripheral T cell unresponsiveness to EAE in vivo.
Materials and Methods
Induction of EAE. Lewis rats, 6-8 wk old, were obtained from
Harlan Sprague Dawley Inc. (Indianapolis, IN) or were bred in our own animal facility. EAE was induced by immunizing the animals in the foot pad with 50 gg MBP in CFA, which was prepared by mixing IFA (Sigma Chemical Co., St. Louis, MO) with 4 mg/ml mycobacterium (GIBCO BRL, Gaithersburg, MD). Scoring of clinical disease was performed as previously described (15, 19, 20) . Briefly, duration of disease was calculated by counting the total number of days from clinical onset to recovery for individual animals; mean duration of disease was calculated as the average for the whole group. Maximal grade was defined as the highest clinical grade achieved by individual animals; mean maximal grade was calculated as the average for each group. Statistical analysis was performed using a one-tailed Student's t test (n = 4-5 per group). Disease index is a composite score and was calculated as follows: mean duration of disease x mean highest disease grade x incidence (19) .
Antigens. Preparation of guinea pig MBP was performed as previously described (19 Intrathymic Injections. Animals were injected intrathymically with synthetic peptides dissolved in sterile PBS as previously described (14, 15) . Intrathymic injections were performed with the animals under ether anesthesia by exposing the thymus through a small suprasternal incision. Volumes of up to 50 #1 can be injected into each lobe, without evidence of leakage, using a 27-30 gauge needle. Thymic injections were performed 48-72 h before immunization.
Isolation of Nylon Wool-adherent Cells. Thymus was isolated from
naive Lewis animals and mashed through a metal sieve to obtain a single-cell suspension. The cells were washed and resuspended at 2-3 x 106/ml and then incubated for 1 h at 37~ over 20-ml nylon wool columns containing 10% FCS in KPMI. (22), and a small-cell population that consisted mostly of thymocytes (TCK +, EDI-, ED2-, ED3-, OX-33-, class I § , and class II-). These thymocytes constituted 10-20% of the total population. Notably, B cell contamination (OX-33) was negligible (<1%). The dendritic-enriched cells had the typical dendritic structure when viewed on cytospin slides and strongly expressed class-II MHC antigen; some of these cells also expressed OX-62, which stains rat veiled cell-enriched populations (24) . Functionally, the dendritic-enriched cells were potent APCs and were capable of inducing significant proliferation (SI = 700) of a peptide T cell clone at ratios of dendritic/responder as low as 1:30 (data not shown).
In Vitro Pulsing of APCs. Nylon wool-adherent cells or dendritic-enriched cells were incubated with antigen at a concentration of 50 gg/ml for 3 h at 37~ and then washed twice to remove excess antigen.
Reverse Transcr~tion PCR. Total cellular KNA was extracted from brain sections using RNAzol B (Cinna/Biotecx, Friendswood, TX), and cDNA was prepared as previously described (25 G3PDH 5' TGA AGG TCG GTG TCA ACG GAT TTG GC; 3' CAT GTA GGC CAT GAG GTC CAC CAC (reference 29) (58"C, 22 cycles) [32p]dCTP incorporated into PCR product bands was measured from dried agarose gels on a Phosphorlmager (Molecular Dynamics, Sunnyvale, CA) as described (25, 26) . PCR amplification with the G3PDH housekeeping gene was performed to assess variations in total KNA or cDNA loading between samples. The mean obtained from at least three analyses was used to normalize other transcript level measurements from the same sample. Corrected values were derived by dividing the measured 32p value for the transcript of interest by the mean G3PDH value for the sample. Relative transcript levels were then determined from cDNA sets that included negative control samples (for which reverse transcriptase had been omitted during cDNA synthesis or water had been used instead of cDNA) performed in the same evaluation. PCK analysis was performed in duplicate on all cDNA samples in an experimental set. The experimental set included cDNAs from the brains of naive rats (n = 3), rats immunized with MBP without treatment to induce EAE (n = 5), rats immunized with MBP after intrathymic injection of p21-40 as control (n = 6), and after intrathymic injection of p71-90 to inhibit EAE (n = 6). Each bar in Fig. 2 represents the mean corrected levels obtained by pooling the levels obtained from all animals per group that had been analyzed in duplicate. Results were subjected to multivariate analysis of variance (MANOVA) without replication.
Immunohistology. The extent of correlation of V~ usage in situ with mKNA data was sought by immunohistologic analysis of sections of rat brain and spleen sections at day 14 (n = 3 per group) using mAbs to V/~8.2 and control V/310 (PharMingen, San Diego, CA). Immunoperoxidase labeling was performed using a sensitive four-layer peroxidase-antiperoxidase technique, as previously described (15, 20) .
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Results
Intrathymic Injection of p71-90 of CP-MBr" Protects Animah from e.AE Even After 30-,; D L,y of Im,n,ni .ation. In our initial studies, we showed that intrathymic injection ofp71-90 but not p21-40 24 h, 48 h, or 1 wk before immunization prevented development of clinical EAE. In the current study, animals injected intrathymically with p71-90 or p21-40 were immunized 30 d after intrathymic injection and were observed for disease. As seen in Fig. 1 , animals injected with p71-90 were completely protected from development of EAE compared with control animals injected intrathymically with p21-40. The incidence in the p21-40 injected group was 5/5 with a mean duration of 5.4 + 0.6 d and a mean grade of 3.0 _+ 0, whereas none of the p71-90-injected animals were sick. These observations indicated to us that the thymic APCs, which are presenting p71-90 to primed T cells had to have the unique characteristics of holding on to antigen for a prolonged period of time.
Thymic Nylon Wool-adherent Cells Pulsed In Vitro with p 71-90 Inhibit EAE.
We tested the hypothesis that thymic nylon wool-adherent cells recognize and present antigen to primed T cells. Thymic nylon wool-adherent cells from a naive animal were pulsed in vitro with GP-MBP for 3 h at 37~ and then added to responder T cells at various ratios. Splenic nylon wool-adherent cells served as control APCs. Thymic nylon wool-adherent cells were able to present antigen to primed T cells (SI = 24 and ~ CPM = 31,611 at a ratio of 1:2, SI = 30 and ~CPM = 39,117 at a ratio of 1:5, SI = 11 and aCPM = 14,681 at a ratio of 1:10, and SI = 2.3 and a CPM = 1,780 at a ratio of 1:100). We then tested the hypothesis that nylon wool-adherent cells pulsed with the encephalitogenic peptide p71-90 and injected intravenously lead to systemic tolerance in vivo. We isolated nylon wool-adherent cells from naive thymus and pulsed them in vitro for 3 h at 37~ with 50/~g/ml p71-90 or p21-40. The cells were then washed twice to get rid of excess peptides and injected intravenously into naive Lewis animals. The recipients were immunized 48-72 h later with MBP/CFA. Significant pro- (Table I b) . Again, a dose-response effect was observed such that injection of 1.5 x 106 cells caused a decrease in severity of disease without affecting incidence (data not shown). Furthermore, injection of 4 x 106 thymic non-plastic-adherent cells (after 2 h incubation) pulsed in vitro with p71-90 was not protective (Table 1 c), providing evidence that the plastic-adherent, dendritic cell-enriched population (that become nonadherent after overnight incubation), and not contaminating thymocytes or thymic B cells, is responsible for induction of tolerance. Depletion of Fc receptor-positive cells from the dendritic-enriched cell population by incubation over immunoglobulin-coated plates did not result in loss of disease protection, suggesting that potentially contaminating macrophages do not contribute to this effect (data not shown).
To address the question of whether thymic dendritic cells were unique in their capability to induce tolerance, we injected dendritic-enriched splenic cells pulsed in vitro with p71-90 intravenously into naive recipients, which were then immunized. Table 2 shows that a splenic dendritic-euriched population pulsed in vitro with p71-90 did not protect the recipients from EAE. Furthermore, parallel experiments showed that injection of p71-90 at a dose of 100/~g intravenously did not protect animals from EAE (Table 2 ). This provides evidence against the carry-over of peptide by nonspecific adherence to cells as a mechanism for protection.
Ttrymectomy before Injection of Dendritic-enriched Cells Abrogates
Pwtectionfwm EAE. Animals were thymectomized and then injected intravenously with thymic dendritic-enriched cells pulsed in vitro with p71-90 and immunized 48 h later. Control animals were thymectomized and then immunized. Table  3 shows that thymic dendritic-enriched cells were not protective when injected into thymectomized recipients. As expected, splenic dendritic-enriched cells pulsed in vitro and injected into thymectomized recipients also were not protective. These data suggest that the native thymus is required for induction of tolerance by intravenous injection of antigenpulsed dendritic cells.
Transfer of Dendritic-enriched Cells frora Intrat~mically Injected
Animals Inhibits EAE. The observations described above, although suggestive, do not provide direct evidence that thymic dendritic-enriched cells are responsible for induction of acquired thymic tolerance. To study this further, thymic dendritic-enriched cells were isolated from the thymus of Lewis rats 2 d after intrathymic injection of p71-90 or p21-40. After Each group consisted of five animals. There were no significant differences in incidence, duration, or severity of disease between the groups. 
Specific Downregulation of TCR Vf18.2 Infiltrating T Cells in the Brain.
There is evidence that the encephalitogenic CD4 + T ceils that initiate the immune response in the rat EAE preferentially use the TCR V38.2 (30) . We studied the expression of this TCR in the brains of naive animals, animals immunized with MBP/CFA, and animals intrathymically tolerized with the immunodominant peptide p71-90 or the control peptide p21-40. Brain RNA was extracted and the samples analyzed by RT-PCR for expression of V/~8.2, and CD4 messages. G3PDH was used as a reference gene, and quantitation of PCR products was expressed as a ratio of the relevant gene to that of G3PDH. Fig. 3 shows that on day 14 (peak of disease), immunized animals had significantly increased expression of CD4 and V38.2 transcripts (P = 0.001) compared with naive animals. Animals injected intrathymically with p21-40 had no significant change in expression of these molecules compared with immunized controls, whereas animals injected with p71-90 showed significantly decreased expression of CD4 and of V38.2 transcripts (P <0.001).
Immunohistologic studies with specific mAbs against V38.2 and a specificity control TCR VB10 confirmed that V38.2 + T cells were selectively decreased by intrathymic injection of p71-90 compared with p21-40. As shown in Fig. 4 , brains from animals injected with p21-40 showed 10-20 V38.2 + T cells per high power field, whereas samples from rats injected with p71-90 showed <1 V38.2 + T cell per high Each group consisted of five animals. There were no significant differences in incidence, duration, or severity of disease between the groups.
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Khoury et al. power field, mAb against V310 was used as a positive control antibody and showed comparable infiltration by V310 + T cells in the brains of animals injected intrathymically with p21-40 or p71-90. Intrathymic injection of p71-90 had no effect on TCR V3 expression in corresponding spleen specimens, in which the numbers of V38.2 + T cells were consistently 50% or less that of V310 + T cells (Fig. 4) . These data indicate that intrathymic injection of p71-90 results in specific inactivation of V38.2 before they home to the brain.
Discussion
In our previous studies, we determined that thymectomy after intrathymic injection and up to day 7 after immuniza- tion would abrogate acquired thymic tolerance (15) . This suggested that a thymic cell population was actively involved in the induction phase of acquired thymic tolerance. Some APCs are capable of presenting antigen in a way that favors tolerogenesis (31, 32) . Dendritic cells were shown to take up antigen from the anterior chamber of the eye and transport it systemically to be presented in the periphery, causing immune deviation (33) . They are known to express high levels of class II MHC (22, 34) and to capture antigen in an immunogenic form in situ (35) . They are extremely efficient APCs in vitro (36, 37) and in vivo (38) . Our data indicate that a population enriched with thymic dendritic cells incubated in vitro with the encephalitogenic MBP peptide p71-90 and injected systemically into naive animals mimics the effects of intrathymic injection of p71-90 (15) .
The dendritic cell-enriched population may be contaminated with other professional APCs (B ceUs or macrophages), which potentially could be mediating the tolerogenic effects. We show that intrathymic injection of peptide continues to be effective at preventing disease even after a 30-d delay in immunization. Because the antigen is injected in soluble form, it is not expected to be retained as free antigen for a prolonged period in the thymus; it is more likely to be retained on the surface of APCs. Dendritic cells retain antigen more efficiently than macrophages (38, 39) , which have a rapid turnover of antigen-presenting activity (40) , suggesting that 30 d after intrathymic injection, the peptide is more likely to be on the surface of thymic dendritic cells than on the surface of macrophages. Thymic B cells were shown to mediate neonatal tolerance by causing clonal deletion (23), but our preparation contained <1% B cells, as assessed by flow cytometry. Dendritic cells adhere to plastic initially but become nonadherent after overnight culture (34) , so washing non-plasticadherent cells after 2 h of incubation removes contaminating thymocytes and B cells. This nonadherent cell population was incapable of inducing tolerance after in vitro incubation with p71-90. Furthermore, the small size of the dendritic cell-enriched population required in our model strongly argues in favor of the dendritic population rather than macrophages or B cells because dendritic cells are very efficient APCs (38, 39) . Carry-over of antigen as a mechanism is unlikely because the cells are washed repeatedly before injection, the control nonadherent population failed to induce tolerance after the same in vitro incubation with antigen, and injection of 100/~g of peptide intravenously was not protective.
In vitro incubation of dendritic cells allowed us to control the conditions of the experiment and ensured that the dendritic cells were exposed to the antigen before injection. To establish the link between our in vitro system and the in vivo intrathymic injection, we isolated dendritic cells from animals injected intrathymically with p71-90 or p21-40 and transferred them intravenously into naive recipients without in vitro pulsing with peptides. Protection of the recipients suggests that dendritic cells were exposed to antigen in vivo and that thymic dendritic cells are mediating acquired thymic tolerance. Dendritic cells have been shown to present antigen and prime naive T cells in vivo (38) . Interestingly, in our model, the outcome of antigen being presented by dendritic cells is suppression of disease and suppression of proliferation of primed lymph node cells (15) . This may result from anergizing/deletion of antigen-specific T calls (41, 42) or, alternatively, from the generation of an intermediate regulatory cell that suppresses antigen-specific T cells in vitro and in vivo. Trapping of antigen-reactive cells in the spleen or lymph nodes, thus preventing them from reaching the target organ, is ruled out by the finding that thymectomy before administration of pulsed dendritic calls abrogates protection. This observation suggests that the interaction between dendritic ceils and antigen-specific T cells may be occurring in the thymus, where activated cells can circulate (16) . Although the relative number of activated T cells circulating through the thymus at any time point is small (43, 44) , this process may be a dynamic one, and, theoretically, most activated T cells may become inactivated or deleted in the thymus over a period of time. This is consistent with our previous observation that the thymus is required for the induction of tolerance for up to 7 d after intrathymic injection (15) .
The findings that splenic dendritic cells do not duplicate the tolerogenic effect of thymic dendritic ceils and that thymectomy abrogates" protection from EAE raise the possibility that thymic dendritic cells home to the thymus, whereas peripheral dendritic cells are unable to do so. In their work on anterior chamber-associated immune deviation, Wilbanks et al. showed that peripheral APCs were unable to duplicate the effect of anterior chamber cells in inducing immune deviation unless the peripheral APCs were preincubated with TGF-/$ (31, 45) .
How could the interaction between thymic dendritic cells and activated T cells result in a tolerogenic signal? The observation that maturing thymocytes have very high cell-surface expression of receptors for thromboxane A2 (TxA2) (46), a potent aggregating and vasoconstrictor agent (47) , suggested that TxA2 elaborated by thymic stromal cells might act as the key signal for cellular events related to T cell development. A TxA2 agonist, but not an inactive metabolite, induced concentration-dependent DNA fragmentation in CD4 + CD8 + cells (46) , which was inhibited by a specific antagonist. Work from Remuzzi et al. in a rat transplantation model showed that blocking TxA2 with a specific receptor antagonist abrogates acquired thymic tolerance to renal allografts induced by intrathymic injection of MHC allopeptides (18) . Thymic dendritic cells abundantly express the enzymatic machinery to synthesize TxA2 (48) . We suggest that the interaction between thymic dendritic cells and activated T cells leads to a series of events that involve the TxA2/TxA2 receptor, thus triggering intracellular events that increase cytoplasmic calcium (49, 50) and resulting in T cell anergy or deletion by apoptosis (46) . In a murine model of EAE, Cross et al. showed that antigenspecific encephalitogenic cells initiate the inflammatory response in the brain, which is perpetuated by nonspecific cells recruited from the periphery (51) . In Lewis rats, the encephalitogenic T cells preferentially express Vf18.2 (30) . We show by immunohistology that the frequency of Vfl8.2-expressing cells in the spleens of naive or immunized animals is less than that of VB10 expressing cells, whereas in the brains, Vf18.2 + cells are equal or more numerous than V~10 + cells at the peak of disease, which is consistent with the hypothesis that VBS.2 + antigen-specific encephalitogenic cells initiate the inflammatory response in the brain. We also show that animals intrathymically injected with p71-90 expressed significantly lower levels of V~8.2 and CD4 message than animals injected with p21-40. This was confirmed at the protein level by decreased staining of VB8.2 + cells in the brains of intrathymically tolerized animals. Interestingly, there was an equivalent number of V~10* T cells in the brains of animals intrathymically injected with p21-40 or p71-90. Whether the encephalitogenic cells are anergized or actually deleted before homing to the brain is unknown; however, we found that in our model administration of IL-2 in vivo did not abrogate protection from EAE (data not shown). Since one form of anergy is reversible by exposure to IL-2 (52, 53) and, in some models, in vivo administration oflL-2 abrogates tolerance (41, 54) , our observation suggests that IL-2-responsive anergy is not responsible for the protection that we observed, and studies with specific TCR transgenic mice are under way to further delineate these mechanisms.
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